October 2009

Teaser

November December 2009

Teaser

Winter 2010

Teaser

  • Abbott Receives FDA Approval for New Cataract Multifoca...
    From Abbott Medical Optics
    ABBOTT PARK, Ill. -- Abbott announced today it has received U.S. Food and Drug Administration (FDA) approval for the TECNIS Multifocal 1-Piece intraocular lens (IOL) for ... (Read more)
  • Professor Discovers Link That Could Help Treatments For...
    From Medical News Today
    What began as research into how diabetics could possibly preserve their eyesight has led to findings that could prolong the vision of children afflicted with retinoblasto... (Read more)
  • Bioness to Distribute New Products for Neurologically I...
    From Business Wire
    VALENCIA, Calif. -- Bioness Inc., a leading neuromodulation company, announced today two agreements to distribute new devices for patients experiencing neurological impai... (Read more)
  • Carb Intake Tied to Cataract Risk
    From Natural Products Insider
    MELBOURNE, Australia—Women who consume higher amounts of carbohydrates appear to have a greater risk of developing cortical and nuclear lens opacities, according to new... (Read more)
  • Novartis announces $5 billion bond issue to fund Alcon ...
    From CNBC
    BASEL, Switzerland - Swiss drug maker Novartis AG announced Wednesday a $5 billion bond issue to finance its purchase of eye-care company Alcon Inc. The pharmaceuticals c... (Read more)

Subscribe to EyewireToday.com

e-dition

Mission Statement

Glaucoma Today is mailed quarterly to 12,706 glaucoma specialists and general ophthalmologists who treat patients with glaucoma. Since 2008, this database has grown by approximately 20%. Glaucoma Today delivers important information on recent research, surgical techniques, clinical strategies, therapeutics, and technology. Additionally, the publication profiles leaders in the field of glaucoma, and contributing authors present challenging cases as a source of education for readers. Glaucoma Today delivers balanced coverage of the topics that matter most.

Meetings

  • Check back soon for upcoming events.